Financial Ratios

AMEYA LABORATORIES LTD.

NSE : NABSE : 532981ISIN CODE : INE450H01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.240 (0 %)
PREV CLOSE ( ) 0.24
OPEN PRICE ( ) 0.23
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.23 (1374)
VOLUME 226104
TODAY'S LOW / HIGH ( )0.23 0.25
52 WK LOW / HIGH ( ) 0.230.25
NSE
This Company is not listed in NSE
Select year
ParticularsMar2012Mar2011Mar2010Mar2009Mar2008
Operational & Financial Ratios
   Earnings Per Share (Rs)0.140.540.8813.5121.77
   CEPS(Rs)0.450.720.960.751.17
   DPS(Rs)0.000.000.100.801.50
   Book NAV/Share(Rs)6.706.486.40115.5362.46
   Tax Rate(%)45.8137.3318.5637.0735.56
Margin Ratios
   Core EBITDA Margin(%)14.1315.8516.5818.9320.11
   EBIT Margin(%)11.3912.9316.7318.8621.65
   Pre Tax Margin(%)2.277.2411.8914.6416.67
   PAT Margin (%)1.234.549.689.2110.74
   Cash Profit Margin (%)3.976.0710.5610.1711.58
Performance Ratios
   ROA(%)1.104.618.369.3217.41
   ROE(%)2.138.4314.4017.0843.24
   ROCE(%)11.6015.3317.5924.5348.19
   Asset Turnover(x)0.901.020.861.011.62
   Sales/Fixed Asset(x)2.333.515.365.936.58
   Working Capital/Sales(x)5.087.511.391.282.52
Efficiency Ratios
   Fixed Capital/Sales(x)0.430.290.190.170.15
   Receivable days90.3176.67107.7087.3932.85
   Inventory Days88.4090.17120.83128.8197.40
   Payable days12.6529.0059.2565.1258.83
Valuation Parameters
   PER(x)12.445.747.520.970.00
   PCE(x)3.854.306.8917.590.00
   Price/Book(x)0.260.481.032.270.00
   Yield(%)0.000.001.520.30
   EV/Net Sales(x)0.630.611.152.200.32
   EV/Core EBITDA(x)4.243.596.1210.081.27
   EV/EBIT(x)5.334.406.4510.601.32
   EV/CE(x)0.510.570.841.580.38
   M Cap / Sales0.160.280.781.970.00
Growth Ratio
   Net Sales Growth(%)-1.7033.3627.176.9039.50
   Core EBITDA Growth(%)-13.0919.929.65-6.7156.87
   EBIT Growth(%)-15.212.829.47-7.7857.21
   PAT Growth(%)-73.93-37.6829.70-9.2236.40
   EPS Growth(%)-73.93-38.42-93.52-37.9331.77
Financial Stability Ratios
   Total Debt/Equity(x)0.800.610.530.290.79
   Current Ratio(x)1.481.355.545.143.20
   Quick Ratio(x)0.900.723.393.031.39
   Interest Cover(x)1.252.273.454.474.35
   Total Debt/Mcap(x)3.061.280.510.13

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.